Top

Gepubliceerd in:

29-05-2024 | Review

Global quality of life and mortality risk in patients with cancer: a systematic review and meta-analysis

Auteurs: Takuya Fukushima, Katsuyoshi Suzuki, Takashi Tanaka, Taro Okayama, Junichiro Inoue, Shinichiro Morishita, Jiro Nakano

Gepubliceerd in: Quality of Life Research | Uitgave 10/2024

Abstract

Purpose

This systematic review and meta-analysis aimed to examine the impact of global quality of life (QOL) on mortality risk in patients with cancer, considering cancer type and timepoint of QOL assessment.

Methods

A systematic search was conducted using Cumulated Index to Nursing and Allied Health Literature, PubMed/MEDLINE, and Scopus databases from inception to December 2022. Observational studies that assessed QOL and examined mortality risk in patients with cancer were extracted. Subgroup analyses were performed for cancer types and timepoints of QOL assessment.

Results

Overall, global QOL was significantly associated with mortality risk (hazard ratio: 1.06, 95% confidence interval: 1.05–1.07; p < 0.00001). A subgroup analysis based on cancer type demonstrated that lung, head and neck, breast, esophagus, colon, prostate, hematologic, liver, gynecologic, stomach, brain, bladder, bone and soft tissue, and mixed type cancers were significantly associated with mortality risk; however, melanoma and pancreatic cancer were not significantly associated with mortality risk. Additionally, global QOL was associated with mortality risk at all timepoints (pretreatment, posttreatment, and palliative phase); pretreatment QOL had the largest impact, followed by posttreatment QOL.

Conclusion

These findings provide evidence that QOL is associated with mortality risk in patients with cancer at any timepoint. These results indicate the importance of evaluating the QOL and supportive interventions to improve QOL in any phase.

vorige artikel Understanding factors impacting patient-reported outcome measures integration in routine clinical practice: an umbrella review

volgende artikel The MID50 is not insensitive to the distribution of the change score if measurement error is taken into account

Alleen toegankelijk voor geautoriseerde gebruikers

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660CrossRefPubMed

Dyba, T., Randi, G., Bray, F., Martos, C., Giusti, F., Nicholson, N., Gavin, A., Flego, M., Neamtiu, L., Dimitrova, N., Negrão Carvalho, R., Ferlay, J., & Bettio, M. (2021). The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. European Journal of Cancer, 157, 308–347. https://doi.org/10.1016/j.ejca.2021.07.039CrossRefPubMedPubMedCentral

Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17–48. https://doi.org/10.3322/caac.21763CrossRefPubMed

WHOQOL—Measuring Quality of Life| The World Health Organization. (n.d.). Retrieved October 30, 2023, from https://www.who.int/tools/whoqol

Xu, J., Sun, Y., Gong, D., & Fan, Y. (2023). Association between disease-specific health-related quality of life and all-cause mortality in patients with heart failure: A meta-analysis. Current Problems in Cardiology, 48(4), 101592. https://doi.org/10.1016/j.cpcardiol.2023.101592CrossRefPubMed

van Nieuwenhuizen, A. J., Buffart, L. M., Brug, J., Leemans, C. R., & Verdonck-de Leeuw, I. M. (2015). The association between health related quality of life and survival in patients with head and neck cancer: A systematic review. Oral Oncology, 51(1), 1–11. https://doi.org/10.1016/j.oraloncology.2014.09.002CrossRefPubMed

Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008). The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology, 26(8), 1355–1363. https://doi.org/10.1200/JCO.2007.13.3439CrossRefPubMed

Montazeri, A. (2009). Quality of life data as prognostic indicators of survival in cancer patients: An overview of the literature from 1982 to 2008. Health and Quality of Life Outcomes, 7, 102. https://doi.org/10.1186/1477-7525-7-102CrossRefPubMedPubMedCentral

Quinten, C., Coens, C., Mauer, M., Comte, S., Sprangers, M. A. G., Cleeland, C., Osoba, D., Bjordal, K., Bottomley, A., EORTC Clinical Groups. (2009). Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. The Lancet. Oncology, 10(9), 865–871. https://doi.org/10.1016/S1470-2045(09)70200-1CrossRefPubMed

10.

Ediebah, D. E., Quinten, C., Coens, C., Ringash, J., Dancey, J., Zikos, E., Gotay, C., Brundage, M., Tu, D., Flechtner, H. H., Greimel, E., Reeve, B. B., Taphoorn, M., Reijneveld, J., Dirven, L., Bottomley, A., Canadian Cancer Trials Group and the European Organization for Research and Treatment of Cancer. (2018). Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials. Cancer, 124(16), 3409–3416. https://doi.org/10.1002/cncr.31556CrossRefPubMed

11.

Husson, O., de Rooij, B. H., Kieffer, J., Oerlemans, S., Mols, F., Aaronson, N. K., van der Graaf, W. T. A., & van de Poll-Franse, L. V. (2020). The EORTC QLQ-C30 summary score as prognostic factor for survival of patients with cancer in the “Real-World”: Results from the Population-Based PROFILES Registry. The Oncologist, 25(4), e722–e732. https://doi.org/10.1634/theoncologist.2019-0348CrossRefPubMed

12.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71CrossRefPubMedPubMedCentral

13.

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. International Journal of Surgery, 8(5), 336–341. https://doi.org/10.1016/j.ijsu.2010.02.007CrossRefPubMed

14.

Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., & de Haes, J. C. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. JNCI: Journal of the National Cancer Institute, 85(5), 365–376. https://doi.org/10.1093/jnci/85.5.365CrossRefPubMed

15.

Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.CrossRefPubMed

16.

Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (2016). The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11(3), 570–579. https://doi.org/10.1200/JCO.1993.11.3.570CrossRef

17.

Ottawa Hospital Research Institute. (n.d.). Retrieved 12 Sep 2023, from https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

18.

Arraras, J. I., Hernandez, B., Martinez, M., Cambra, K., Rico, M., Illarramendi, J. J., Viudez, A., Ibañez, B., Zarandona, U., Martinez, E., & Vera, R. (2016). Quality of life in Spanish advanced non-small-cell lung cancer patients: Determinants of global QL and survival analyses. Springerplus, 5(1), 836. https://doi.org/10.1186/s40064-016-2559-9CrossRefPubMedPubMedCentral

19.

Badaoui, S., Shahnam, A., McKinnon, R. A., Abuhelwa, A. Y., Sorich, M. J., & Hopkins, A. M. (2022). The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy. Translational Lung Cancer Research, 11(3), 432–439. https://doi.org/10.21037/tlcr-21-938CrossRefPubMedPubMedCentral

20.

Dharma-Wardene, M., Au, H. J., Hanson, J., Dupere, D., Hewitt, J., & Feeny, D. (2004). Baseline FACT-G score is a predictor of survival for advanced lung cancer. Quality of Life Research, 13(7), 1209–1216. https://doi.org/10.1023/B:QURE.0000037481.36604.ebCrossRefPubMed

21.

Erdem, R. (2022). Association between change in quality of life and survival in advanced non-small-cell lung cancer. Turkish Journal of Oncology., 37(3), 246–253. https://doi.org/10.5505/tjo.2022.3375CrossRef

22.

Fielding, R., & Wong, W. S. (2007). Quality of life as a predictor of cancer survival among Chinese liver and lung cancer patients. European Journal of Cancer (Oxford, England: 1990), 43(11), 1723–1730. https://doi.org/10.1016/j.ejca.2007.05.002CrossRefPubMed

23.

Hui, D., Darke, A. K., Guthrie, K. A., Subbiah, I. M., Unger, J. M., Hershman, D. L., Krouse, R. S., Bakitas, M., & O’Rourke, M. A. (2022). Association between health-related quality of life and progression-free survival in patients with advanced cancer: A secondary analysis of SWOG clinical trials. JCO Oncology Practice, 18(4), e442–e451. https://doi.org/10.1200/OP.21.00407CrossRefPubMed

24.

Jacot, W., Colinet, B., Bertrand, D., Lacombe, S., Bozonnat, M. C., Daurès, J. P., Pujol, J. L., OncoLR health network. (2008). Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 19(8), 1458–1464. https://doi.org/10.1093/annonc/mdn064CrossRefPubMed

25.

Kao, S. C., Vardy, J., Harvie, R., Chatfield, M., van Zandwijk, N., Clarke, S., & Pavlakis, N. (2013). Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 21(3), 697–705. https://doi.org/10.1007/s00520-012-1569-6CrossRefPubMed

26.

Langendijk, H., Aaronson, N. K., de Jong, J. M., ten Velde, G. P., Muller, M. J., & Wouters, M. (2000). The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 55(1), 19–25. https://doi.org/10.1016/s0167-8140(00)00158-4CrossRefPubMed

27.

Lemonnier, I., Guillemin, F., Arveux, P., Clément-Duchêne, C., Velten, M., Woronoff-Lemsi, M. C., Jolly, D., & Baumann, C. (2014). Quality of life after the initial treatments of non-small cell lung cancer: A persistent predictor for patients’ survival. Health and Quality of Life Outcomes, 12, 73. https://doi.org/10.1186/1477-7525-12-73CrossRefPubMedPubMedCentral

28.

Li, T. C., Li, C. I., Tseng, C. H., Lin, K. S., Yang, S. Y., Chen, C. Y., Hsia, T. C., Lee, Y. D., & Lin, C. C. (2012). Quality of life predicts survival in patients with non-small cell lung cancer. BMC Public Health, 12, 790. https://doi.org/10.1186/1471-2458-12-790CrossRefPubMedPubMedCentral

29.

Movsas, B., Moughan, J., Sarna, L., Langer, C., Werner-Wasik, M., Nicolaou, N., Komaki, R., Machtay, M., Wasserman, T., & Bruner, D. W. (2009). Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27(34), 5816–5822. https://doi.org/10.1200/JCO.2009.23.7420CrossRefPubMed

30.

Nieto-Guerrero Gómez, J. M., Silva Vega, G. P., Cacicedo, J., Delgado León, B. D., Herrero Rivera, D., Praena Fernández, J. M., Rivin Del Campo, E., Ortiz Gordillo, M. J., & López Guerra, J. L. (2020). Impact of pre-radiation therapy quality of life in lung cancer survival: A prospective, intention-to-treat, multicenter study. Clinical and Translational Oncology, 22(9), 1635–1644. https://doi.org/10.1007/s12094-020-02310-0CrossRefPubMed

31.

O’Mahony, S., Nathan, S., Mohajer, R., Bonomi, P., Batus, M., Fidler, M. J., Wells, K., Kern, N., Sims, S., & Amin, D. (2016). Survival prediction in ambulatory patients with stage III/IV non-small cell lung cancer using the palliative performance scale, ECOG, and lung cancer symptom scale. The American Journal of Hospice & Palliative Care, 33(4), 374–380. https://doi.org/10.1177/1049909115570707CrossRef

32.

Pompili, C., Omar, S., Ilyas, M. H., Velikova, G., Dalmia, S., Valuckiene, L., Alexopoulos, P., & Brunelli, A. (2023). Patient-reported physical function is associated with survival after lung resection for non-small cell lung cancer. The Annals of Thoracic Surgery, 116(3), 563–569. https://doi.org/10.1016/j.athoracsur.2022.09.047CrossRefPubMed

33.

Qi, Y., Schild, S. E., Mandrekar, S. J., Tan, A. D., Krook, J. E., Rowland, K. M., Garces, Y. I., Soori, G. S., Adjei, A. A., & Sloan, J. A. (2009). Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer, 4(9), 1075–1082. https://doi.org/10.1097/JTO.0b013e3181ae27f5CrossRefPubMed

34.

Sloan, J. A., Cheville, A. L., Liu, H., Novotny, P. J., Wampfler, J. A., Garces, Y. I., Clark, M. M., & Yang, P. (2016). Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship. Health and Quality of Life Outcomes, 14, 66. https://doi.org/10.1186/s12955-016-0461-3CrossRefPubMedPubMedCentral

35.

Sloan, J. A., Zhao, X., Novotny, P. J., Wampfler, J., Garces, Y., Clark, M. M., & Yang, P. (2012). Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 30(13), 1498–1504. https://doi.org/10.1200/JCO.2010.33.4631CrossRefPubMed

36.

Trejo, M. J., Bell, M. L., Dhillon, H. M., & Vardy, J. L. (2020). Baseline quality of life is associated with survival among people with advanced lung cancer. Journal of Psychosocial Oncology, 38(5), 635–641. https://doi.org/10.1080/07347332.2020.1765065CrossRefPubMedPubMedCentral

37.

Yun, Y. H., Kim, Y. A., Sim, J. A., Shin, A. S., Chang, Y. J., Lee, J., Kim, M. S., Shim, Y. M., & Zo, J. L. (2016). Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer. BMC Cancer, 16, 505. https://doi.org/10.1186/s12885-016-2504-xCrossRefPubMedPubMedCentral

38.

Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2001). Quality of life in lung cancer patients: As an important prognostic factor. Lung Cancer (Amsterdam, Netherlands), 31(2–3), 233–240. https://doi.org/10.1016/s0169-5002(00)00179-3CrossRefPubMed

39.

Fang, F. M., Liu, Y. T., Tang, Y., Wang, C. J., & Ko, S. F. (2004). Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer, 100(2), 425–432. https://doi.org/10.1002/cncr.20010CrossRefPubMed

40.

Mehanna, H. M., & Morton, R. P. (2006). Does quality of life predict long-term survival in patients with head and neck cancer? Archives of Otolaryngology-Head & Neck Surgery, 132(1), 27–31. https://doi.org/10.1001/archotol.132.1.27CrossRef

41.

Oskam, I. M., Verdonck-de Leeuw, I. M., Aaronson, N. K., Kuik, D. J., de Bree, R., Doornaert, P., Langendijk, J. A., & Leemans, C. R. (2010). Quality of life as predictor of survival: A prospective study on patients treated with combined surgery and radiotherapy for advanced oral and oropharyngeal cancer. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 97(2), 258–262. https://doi.org/10.1016/j.radonc.2010.02.005CrossRefPubMed

42.

Tarsitano, A., Pizzigallo, A., Ballone, E., & Marchetti, C. (2012). Health-related quality of life as a survival predictor for patients with oral cancer: Is quality of life associated with long-term overall survival? Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 114(6), 756–763. https://doi.org/10.1016/j.oooo.2012.06.022CrossRefPubMed

43.

Lango, M. N., Egleston, B., Fang, C., Burtness, B., Galloway, T., Liu, J., Mehra, R., Ebersole, B., Moran, K., & Ridge, J. A. (2014). Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer, 120(6), 840–847. https://doi.org/10.1002/cncr.28482CrossRefPubMed

44.

Xiao, C., Zhang, Q., Nguyen-Tân, P. F., List, M., Weber, R. S., Ang, K. K., Rosenthal, D., Filion, E. J., Kim, H., Silverman, C., Raben, A., Galloway, T., Fortin, A., Gore, E., Winquist, E., Jones, C. U., Robinson, W., Raben, D., Le, Q. T., & Bruner, D. (2017). Quality of life and performance status from a substudy conducted within a prospective phase 3 randomized trial of concurrent standard radiation versus accelerated radiation plus cisplatin for locally advanced head and neck carcinoma: NRG Oncology RTOG 0129. International Journal of Radiation Oncology, Biology, Physics, 97(4), 667–677. https://doi.org/10.1016/j.ijrobp.2016.07.020CrossRefPubMed

45.

Yang, C. J., Roh, J. L., Kim, M. J., Lee, S., Kim, S. B., Choi, S. H., Nam, S. Y., & Kim, S. Y. (2016). Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 25(1), 165–174. https://doi.org/10.1007/s11136-015-1063-yCrossRefPubMed

46.

Aarstad, H. J., Osthus, A. A., Olofsson, J., & Aarstad, A. K. H. (2014). Level of distress predicts subsequent survival in successfully treated head and neck cancer patients: A prospective cohort study. Acta oto-laryngologica, 134(2), 211–219. https://doi.org/10.3109/00016489.2013.841989CrossRefPubMed

47.

Rogers, S. N., Waylen, A. E., Thomas, S., Penfold, C., Pring, M., Waterboer, T., Pawlita, M., Hurley, K., & Ness, A. R. (2020). Quality of life, cognitive, physical and emotional function at diagnosis predicts head and neck cancer survival: Analysis of cases from the Head and Neck 5000 study. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): Affiliated with the German Society for Oto-Rhino-Laryngology—Head and Neck Surgery, 277(5), 1515–1523. https://doi.org/10.1007/s00405-020-05850-xCrossRefPubMed

48.

Ishiyama, H., Kawakami, S., Sekiguchi, A., Kainuma, T., Miyamoto, S., Yamashita, T., & Nakano, M. (2022). Quality of life score as a prognosticator for pharyngeal cancer patients treated with radiotherapy. Scientific reports, 12(1), 2387. https://doi.org/10.1038/s41598-022-06441-yCrossRefPubMedPubMedCentral

49.

Liao, K. C., Chuang, H. C., Chien, C. Y., Lin, Y. T., Tsai, M. H., Su, Y. Y., Yang, C. H., Lai, C. C., Huang, T. L., Li, S. H., Lee, T. F., Lin, W. T., Lee, C. H., & Fang, F. M. (2021). Quality of life as a mediator between cancer stage and long-term mortality in nasopharyngeal cancer patients treated with intensity-modulated radiotherapy. Cancers, 13(20), 5063. https://doi.org/10.3390/cancers13205063CrossRefPubMedPubMedCentral

50.

Kramer, J. A., Curran, D., Piccart, M., de Haes, J. C., Bruning, P., Klijn, J., Van Hoorebeeck, I., & Paridaens, R. (2000). Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. European Journal of Cancer (Oxford, England: 1990), 36(12), 1498–1506. https://doi.org/10.1016/s0959-8049(00)00144-1CrossRefPubMed

51.

Luoma, M.-L., Hakamies-Blomqvist, L., Sjöström, J., Pluzanska, A., Ottoson, S., Mouridsen, H., Bengtsson, N. O., Bergh, J., Malmström, P., Valvere, V., Tennvall, L., & Blomqvist, C. (2003). Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. European Journal of Cancer (Oxford, England: 1990), 39(10), 1370–1376. https://doi.org/10.1016/s0959-8049(02)00775-xCrossRefPubMed

52.

Efficace, F., Biganzoli, L., Piccart, M., Coens, C., Van Steen, K., Cufer, T., Coleman, R. E., Calvert, H. A., Gamucci, T., Twelves, C., Fargeot, P., Bottomley, A., & Bottomley, A. (2004). Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. European Journal of Cancer (Oxford, England: 1990), 40(7), 1021–1030. https://doi.org/10.1016/j.ejca.2004.01.014CrossRefPubMed

53.

Efficace, F., Therasse, P., Piccart, M. J., Coens, C., van Steen, K., Welnicka-Jaskiewicz, M., Cufer, T., Dyczka, J., Lichinitser, M., Shepherd, L., de Haes, H., Sprangers, M. A., & Bottomley, A. (2004). Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: An international multicenter study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 22(16), 3381–3388. https://doi.org/10.1200/JCO.2004.02.060CrossRefPubMed

54.

Epplein, M., Zheng, Y., Zheng, W., Chen, Z., Gu, K., Penson, D., Lu, W., & Shu, X.-O. (2011). Quality of life after breast cancer diagnosis and survival. Journal of Clinical Oncology, 29(4), 406–412. https://doi.org/10.1200/JCO.2010.30.6951CrossRefPubMed

55.

Svensson, H., Hatschek, T., Johansson, H., Einbeigi, Z., & Brandberg, Y. (2012). Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer. Medical Oncology (Northwood, London, England), 29(2), 432–438. https://doi.org/10.1007/s12032-011-9844-9CrossRefPubMed

56.

Gupta, D., Granick, J., Grutsch, J. F., & Lis, C. G. (2007). The prognostic association of health-related quality of life scores with survival in breast cancer. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 15(4), 387–393. https://doi.org/10.1007/s00520-006-0165-zCrossRefPubMed

57.

DiSipio, T., Hayes, S., Battistutta, D., Newman, B., & Janda, M. (2011). Patterns, correlates, and prognostic significance of quality of life following breast cancer. Psycho-Oncology, 20(10), 1084–1091. https://doi.org/10.1002/pon.1816CrossRefPubMed

58.

De Aguiar, S. S., Bergmann, A., & Mattos, I. E. (2014). Quality of life as a predictor of overall survival after breast cancer treatment. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 23(2), 627–637. https://doi.org/10.1007/s11136-013-0476-8CrossRefPubMed

59.

Takada, K., Kashiwagi, S., Fukui, Y., Goto, W., Asano, Y., Morisaki, T., Takashima, T., Hirakawa, K., & Ohira, M. (2019). Prognostic value of quality-of-life scores in patients with breast cancer undergoing preoperative chemotherapy. BJS Open, 3(1), 38–47. https://doi.org/10.1002/bjs5.50108CrossRefPubMed

60.

Coates, A., & Gebski, V. (1996). On the receiving end. Vl. Which dimensions of quality-of-life scores carry prognostic information? Cancer Treatment Reviews, 22, 63–67. https://doi.org/10.1016/S0305-7372(96)90065-1CrossRefPubMed

61.

Diouf, M., Filleron, T., Barbare, J. C., Fin, L., Picard, C., Bouché, O., Dahan, L., Paoletti, X., & Bonnetain, F. (2013). The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma. Journal of Hepatology, 58(3), 509–521. https://doi.org/10.1016/j.jhep.2012.11.019CrossRefPubMed

62.

Steel, J. L., Geller, D. A., Robinson, T. L., Savkova, A. Y., Brower, D. S., Marsh, J. W., & Tsung, A. (2014). Health-related quality of life as a prognostic factor in patients with advanced cancer. Cancer, 120(23), 3717–3721. https://doi.org/10.1002/cncr.28902CrossRefPubMed

63.

Yeo, W., Mo, F. K. F., Koh, J., Chan, A. T. C., Leung, T., Hui, P., Chan, L., Tang, A., Lee, J. J., Mok, T. S., Lai, P. B., Johnson, P. J., & Zee, B. (2006). Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 17(7), 1083–1089. https://doi.org/10.1093/annonc/mdl065CrossRefPubMed

64.

Bonnetain, F., Paoletti, X., Collette, S., Doffoel, M., Bouché, O., Raoul, J. L., Rougier, P., Masskouri, F., Barbare, J. C., & Bedenne, L. (2008). Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: Results from two French clinical trials. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 17(6), 831–843. https://doi.org/10.1007/s11136-008-9365-yCrossRefPubMed

65.

Meier, A., Yopp, A., Mok, H., Kandunoori, P., Tiro, J., & Singal, A. G. (2015). Role functioning is associated with survival in patients with hepatocellular carcinoma. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 24(7), 1669–1675. https://doi.org/10.1007/s11136-014-0895-1CrossRefPubMed

66.

Sternby Eilard, M., Hagström, H., Mortensen, K. E., Wilsgaard, T., Vagnildhaug, O. M., Dajani, O., Stål, P., & Rizell, M. (2018). Quality of life as a prognostic factor for survival in hepatocellular carcinoma. Liver International: Official Journal of the International Association for the Study of the Liver, 38(5), 885–894. https://doi.org/10.1111/liv.13593CrossRefPubMed

67.

Fang, F. M., Tsai, W. L., Chiu, H. C., Kuo, W. R., & Hsiung, C. Y. (2004). Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 58(5), 1394–1404. https://doi.org/10.1016/j.ijrobp.2003.09.100CrossRefPubMed

68.

van Heijl, M., Sprangers, M. A. G., de Boer, A. G. E. M., Lagarde, S. M., Reitsma, H. B., Busch, O. R. C., Tilanus, H. W., van Lanschot, J. J., & van Berge Henegouwen, M. I. (2010). Preoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer. Annals of Surgical Oncology, 17(1), 23–30. https://doi.org/10.1245/s10434-009-0731-yCrossRefPubMed

69.

Bergquist, H., Johnsson, A., Hammerlid, E., Wenger, U., Lundell, L., & Ruth, M. (2008). Factors predicting survival in patients with advanced oesophageal cancer: A prospective multicentre evaluation. Alimentary Pharmacology & Therapeutics, 27(5), 385–395. https://doi.org/10.1111/j.1365-2036.2007.03589.xCrossRef

70.

Djärv, T., & Lagergren, P. (2011). Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery. European Journal of Cancer (Oxford, England: 1990), 47(4), 530–535. https://doi.org/10.1016/j.ejca.2010.10.014CrossRefPubMed

71.

Chang, Y. L., Tsai, Y. F., Chao, Y. K., & Wu, M. Y. (2016). Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 25(2), 465–475. https://doi.org/10.1007/s11136-015-1094-4CrossRefPubMed

72.

McKernan, M., McMillan, D. C., Anderson, J. R., Angerson, W. J., & Stuart, R. C. (2008). The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. British Journal of Cancer, 98(5), 888–893. https://doi.org/10.1038/sj.bjc.6604248CrossRefPubMedPubMedCentral

73.

van Kleef, J. J., Dijksterhuis, W. P. M., van den Boorn, H. G., Prins, M., Verhoeven, R. H. A., Gisbertz, S. S., Slingerland, M., Mohammad, N. H., Creemers, G. J., Neelis, K. J., Heisterkamp, J., Rosman, C., Ruurda, J. P., Kouwenhoven, E. A., van de Poll-Franse, L. V., van Oijen, M. G. H., Sprangers, M. A. G., van Laarhoven, H. W. M., Dutch Upper GI Cancer Group (DUCG). (2021). Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study. Gastric Cancer: Official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 24(6), 1203–1212. https://doi.org/10.1007/s10120-021-01209-1CrossRefPubMed

74.

Collette, L., van Andel, G., Bottomley, A., Oosterhof, G. O. N., Albrecht, W., de Reijke, T. M., & Fossà, S. D. (2004). Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. Journal of Clinical Oncology: Official journal of the American Society of Clinical Oncology, 22(19), 3877–3885. https://doi.org/10.1200/JCO.2004.07.089CrossRefPubMed

75.

Lis, C. G., Gupta, D., & Grutsch, J. F. (2008). Patient satisfaction with health-related quality of life: Implications for prognosis in prostate cancer. Clinical Genitourinary Cancer, 6(2), 91–96. https://doi.org/10.3816/CGC.2008.n.014CrossRefPubMed

76.

Gupta, D., Braun, D. P., & Staren, E. D. (2013). Prognostic value of changes in quality of life scores in prostate cancer. BMC urology, 13, 32. https://doi.org/10.1186/1471-2490-13-32CrossRefPubMedPubMedCentral

77.

Beer, T. M., Miller, K., Tombal, B., Cella, D., Phung, D., Holmstrom, S., Ivanescu, C., Skaltsa, K., & Naidoo, S. (2017). The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies. European Journal of Cancer (Oxford, England: 1990), 87, 21–29. https://doi.org/10.1016/j.ejca.2017.09.035CrossRefPubMed

78.

Gupta, D., Patel, K., & Lis, C. G. (2015). Self-rated health supersedes patient satisfaction with service quality as a predictor of survival in prostate cancer. Health and Quality of Life Outcomes, 13, 137. https://doi.org/10.1186/s12955-015-0334-1CrossRefPubMedPubMedCentral

79.

Roy, S., Morgan, S. C., Spratt, D. E., MacRae, R. M., Grimes, S., Malone, J., Mukherjee, D., & Malone, S. (2022). Association of baseline patient-reported health-related quality of life metrics with outcome in localised prostate cancer. Clinical Oncology (Royal College of Radiologists (Great Britain)), 34(1), e61–e68. https://doi.org/10.1016/j.clon.2021.10.007CrossRef

80.

Jerkeman, M., Kaasa, S., Hjermstad, M., Kvaløy, S., & Cavallin-Stahl, E. (2001). Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: A Nordic Lymphoma Group Trial. Medical Oncology (Northwood, London, England), 18(1), 85–94. https://doi.org/10.1385/MO:18:1:85CrossRefPubMed

81.

Jung, H. A., Park, S., Cho, J. H., Kim, S., Ko, Y. H., Kim, S. J., & Kim, W. S. (2012). Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study. Annals of Hematology, 91(11), 1747–1756. https://doi.org/10.1007/s00277-012-1516-0CrossRefPubMed

82.

Hamilton, B. K., Law, A. D., Rybicki, L., Abounader, D., Dabney, J., Dean, R., Duong, H. K., Gerds, A. T., Hanna, R., Hill, B. T., Jagadeesh, D., Kalaycio, M. E., Lawrence, C., McLellan, L., Pohlman, B., Sobecks, R. M., Bolwell, B. J., & Majhail, N. S. (2015). Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients. Bone Marrow Transplantation, 50(9), 1235–1240. https://doi.org/10.1038/bmt.2015.122CrossRefPubMed

83.

Shaw, B. E., Brazauskas, R., Millard, H. R., Fonstad, R., Flynn, K. E., Abernethy, A., Vogel, J., Petroske, C., Mattila, D., Drexler, R., Lee, S. J., Horowitz, M. M., & Rizzo, J. D. (2017). Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Cancer, 123(23), 4687–4700. https://doi.org/10.1002/cncr.30936CrossRefPubMed

84.

Huang, H., Datye, A., Fan, M., Knapp, A., Nielsen, T., Bottos, A., Paulson, J. N., Trask, P. C., & Efficace, F. (2022). Patient-reported outcomes provide prognostic information for survival in patients with diffuse large B-cell lymphoma: Analysis of 1239 patients from the GOYA study. Cancer Medicine, 11(17), 3312–3322. https://doi.org/10.1002/cam4.4692CrossRefPubMedPubMedCentral

85.

Lindberg, Å., Eskelund, C. W., Albertsson-Lindblad, A., Kolstad, A., Laurell, A., Räty, R., Grønbaek, K., Geisler, C. H., & Jerkeman, M. (2022). Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience. Hematological Oncology, 40(1), 22–30. https://doi.org/10.1002/hon.2940CrossRefPubMed

86.

Kurosawa, S., Yamaguchi, T., Mori, A., Tsukagoshi, M., Okuda, I., Ikeda, M., Fuji, S., Yamashita, T., Ogawa, C., Ito, A., Tanaka, T., Inamoto, Y., Kim, S. W., & Fukuda, T. (2021). Prognostic impact of pretransplantation quality of life and its post-transplantation longitudinal change after allogeneic hematopoietic cell transplantation: A prospective study that administered the Short-Form Health Survey (SF-12) and EuroQol 5. Transplantation and Cellular Therapy, 27(11), 935.e1-935.e9. https://doi.org/10.1016/j.jtct.2021.07.026CrossRefPubMed

87.

Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002). Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer (Oxford, England: 1990), 38(10), 1351–1357. https://doi.org/10.1016/s0959-8049(02)00098-9CrossRefPubMed

88.

Efficace, F., Bottomley, A., Coens, C., Van Steen, K., Conroy, T., Schöffski, P., Schmoll, H., Van Cutsem, E., & Köhne, C. H. (2006). Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? European Journal of Cancer (Oxford, England: 1990), 42(1), 42–49. https://doi.org/10.1016/j.ejca.2005.07.025CrossRefPubMed

89.

Lis, C. G., Gupta, D., Granick, J., & Grutsch, J. F. (2006). Can patient satisfaction with quality of life predict survival in advanced colorectal cancer? Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 14(11), 1104–1110. https://doi.org/10.1007/s00520-006-0100-3CrossRefPubMed

90.

Efficace, F., Innominato, P. F., Bjarnason, G., Coens, C., Humblet, Y., Tumolo, S., Genet, D., Tampellini, M., Bottomley, A., Garufi, C., Focan, C., Giacchetti, S., Lévi, F., & Lévi, F. (2008). Validation of patient’s self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: Results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer. Journal of Clinical Oncology, 26(12), 2020–2026. https://doi.org/10.1200/JCO.2007.12.3117CrossRefPubMed

91.

Braun, D. P., Gupta, D., Grutsch, J. F., & Staren, E. D. (2011). Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer? Health and Quality of Life Outcomes, 9, 62. https://doi.org/10.1186/1477-7525-9-62CrossRefPubMedPubMedCentral

92.

Park, S., Eo, W., & Lee, S. (2018). The relationship between health-related quality of life and survival in metastatic colorectal cancer patients treated with Korean medicine. Integrative Cancer Therapies, 17(1), 65–72. https://doi.org/10.1177/1534735416684015CrossRefPubMed

93.

Dodson, R. M., McQuellon, R. P., Mogal, H. D., Duckworth, K. E., Russell, G. B., Votanopoulos, K. I., Shen, P., & Levine, E. A. (2016). Quality-of-life evaluation after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Annals of Surgical Oncology, 23(Suppl 5), 772–783. https://doi.org/10.1245/s10434-016-5547-yCrossRefPubMedPubMedCentral

94.

Ratjen, I., Schafmayer, C., Enderle, J., di Giuseppe, R., Waniek, S., Koch, M., Burmeister, G., Nöthlings, U., Hampe, J., Schlesinger, S., & Lieb, W. (2018). Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: A German cohort study. BMC Cancer, 18(1), 1156. https://doi.org/10.1186/s12885-018-5075-1CrossRefPubMedPubMedCentral

95.

Hamers, P. A. H., Vink, G. R., Elferink, M. A. G., Stellato, R. K., Dijksterhuis, W. P. M., Punt, C. J. A., Koopman, M., May, A. M., QUALITAS study group. (2022). Quality of life and survival of metastatic colorectal cancer patients treated with trifluridine-tipiracil (QUALITAS). Clinical Colorectal Cancer, 21(2), 154–166. https://doi.org/10.1016/j.clcc.2022.03.002CrossRefPubMed

96.

Ashing-Giwa, K. T., Lim, J.-W., & Tang, J. (2010). Surviving cervical cancer: Does health-related quality of life influence survival? Gynecologic Oncology, 118(1), 35–42. https://doi.org/10.1016/j.ygyno.2010.02.027CrossRefPubMed

97.

Carey, M. S., Bacon, M., Tu, D., Butler, L., Bezjak, A., & Stuart, G. C. (2008). The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecologic Oncology, 108(1), 100–105. https://doi.org/10.1016/j.ygyno.2007.08.088CrossRefPubMed

98.

Kim, M. K., Sim, J. A., Yun, Y. H., Bae, D. S., Nam, J. H., Park, C. T., Cho, C. H., Lee, J. M., & Park, S. Y. (2016). Health-related quality of life and sociodemographic characteristics as prognostic indicators of long-term survival in disease-free cervical cancer survivors. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 26(4), 743–749. https://doi.org/10.1097/IGC.0000000000000665CrossRefPubMed

99.

Park, S. H., Cho, M. S., Kim, Y. S., Hong, J., Nam, E., Park, J., Cho, E. K., Shin, D. B., Lee, J. H., & Lee, W. K. (2008). Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 17(2), 207–214. https://doi.org/10.1007/s11136-008-9307-8CrossRefPubMed

100.

Terashima, M., Fujitani, K., Ando, M., Sakamaki, K., Kawabata, R., Ito, Y., Yoshikawa, T., Kondo, M., Kodera, Y., Kaji, M., Oka, Y., Imamura, H., Kawada, J., Takagane, A., Shimada, H., Tanizawa, Y., Yamanaka, T., Morita, S., Ninomiya, M., & Yoshida, K. (2021). Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by incurable advanced gastric cancer. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 24(1), 224–231. https://doi.org/10.1007/s10120-020-01114-zCrossRefPubMed

101.

Ogoshi, K., Hayashi, F., Takenoshita, S., & Isono, K. (2022). Baseline QOL, QOL-relevant HLA-restricted HERV gene-derived peptides, and survival outcomes in gastric cancer. Annals of Cancer Research and Therapy, 30(2), 55–66. https://doi.org/10.4993/acrt.30.55CrossRef

102.

Mauer, M. E. L., Taphoorn, M. J. B., Bottomley, A., Coens, C., Efficace, F., Sanson, M., Brandes, A. A., van der Rijt, C. C., Bernsen, H. J., Frénay, M., Tijssen, C. C., Lacombe, D., van den Bent, M. J., EORTC Brain Cancer Group. (2007). Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 25(36), 5731–5737. https://doi.org/10.1200/JCO.2007.11.1476CrossRefPubMed

103.

Bragstad, S., Flatebø, M., Natvig, G. K., Eide, G. E., Skeie, G. O., Behbahani, M., Pedersen, P. H., Enger, P. Ø., & Skeie, B. S. (2018). Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: A prospective study. Journal of Neurosurgery, 129(1), 71–83. https://doi.org/10.3171/2017.2.JNS161659CrossRefPubMed

104.

Sehlen, S., Lenk, M., Hollenhorst, H., Schymura, B., Aydemir, U., Herschbach, P., & Dühmke, E. (2003). Quality of life (QoL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy. Onkologie, 26(1), 38–43. https://doi.org/10.1159/000069862CrossRefPubMed

105.

Chiarion-Sileni, V., Del Bianco, P., De Salvo, G. L., Lo Re, G., Romanini, A., Labianca, R., Nortilli, R., Corgna, E., Dalla Palma, M., Lo Presti, G., Ridolfi, R., Italian Melanoma Intergroup (IMI). (2003). Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. European Journal of Cancer (Oxford, England: 1990), 39(11), 1577–1585. https://doi.org/10.1016/s0959-8049(03)00372-1CrossRefPubMed

106.

Brandberg, Y., Johansson, H., Aamdal, S., Bastholt, L., Hernberg, M., Stierner, U., von der Maase, H., Hansson, J., Nordic Melanoma Cooperative Group. (2013). Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma. Acta Oncologica (Stockholm, Sweden), 52(6), 1086–1093. https://doi.org/10.3109/0284186X.2013.789140CrossRefPubMed

107.

Roychowdhury, D. F., Hayden, A., & Liepa, A. M. (2003). Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. Journal of Clinical Oncology, 21(4), 673–678. https://doi.org/10.1200/JCO.2003.04.166CrossRefPubMed

108.

Westhofen, T., Eismann, L., Buchner, A., Schlenker, B., Giessen-Jung, C., Becker, A., Stief, C. G., & Kretschmer, A. (2022). Baseline health-related quality of life predicts bladder cancer-specific survival following radical cystectomy. European Urology Focus, 8(6), 1659–1665. https://doi.org/10.1016/j.euf.2022.02.001CrossRefPubMed

109.

Gupta, D., Lis, C. G., & Grutsch, J. F. (2006). The European organization for research and treatment of cancer quality of life questionnaire: Implications for prognosis in pancreatic cancer. International Journal of Gastrointestinal Cancer, 37(2–3), 65–73. https://doi.org/10.1007/s12029-007-0001-9CrossRefPubMed

110.

Lis, C. G., Gupta, D., & Grutsch, J. F. (2006). Patient satisfaction with quality of life as a predictor of survival in pancreatic cancer. International Journal of Gastrointestinal Cancer, 37(1), 35–44. https://doi.org/10.1385/IJGC:37:1:35CrossRefPubMed

111.

Eichler, M., Singer, S., Hentschel, L., Richter, S., Hohenberger, P., Kasper, B., Andreou, D., Pink, D., Jakob, J., Grützmann, R., Fung, S., Wardelmann, E., Arndt, K., Heidt, V., Bonilla, S. A. Z., Gaidzik, V. I., Jambor, H. K., Weitz, J., Schaser, K. D., … Schuler, M. K. (2022). The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa). British Journal of Cancer, 126(9), 1346–1354. https://doi.org/10.1038/s41416-022-01702-zCrossRefPubMedPubMedCentral

112.

Park, S. M., Park, M. H., Won, J. H., Lee, K. O., Choe, W. S., Heo, D. S., Kim, S. Y., Lee, K. S., & Yun, Y. H. (2006). EuroQol and survival prediction in terminal cancer patients: A multicenter prospective study in hospice-palliative care units. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 14(4), 329–333. https://doi.org/10.1007/s00520-005-0889-1CrossRefPubMed

113.

Coates, A., Porzsolt, F., & Osoba, D. (1997). Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. European Journal of Cancer (Oxford, England: 1990), 33(7), 1025–1030. https://doi.org/10.1016/s0959-8049(97)00049-xCrossRefPubMed

114.

Sehlen, S., Marten-Mittag, B., Herschbach, P., Schweden, M., Book, K., Henrich, G., Dühmke, E., & Dinkel, A. (2012). Health-related quality of life supersedes other psychosocial predictors of long-term survival in cancer patients undergoing radiotherapy. Acta Oncologica (Stockholm, Sweden), 51(8), 1020–1028. https://doi.org/10.3109/0284186X.2012.683879CrossRefPubMed

115.

Lee, Y. J., Suh, S. Y., Choi, Y. S., Shim, J. Y., Seo, A. R., Choi, S. E., Ahn, H. Y., & Yim, E. (2014). EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 22(7), 1941–1948. https://doi.org/10.1007/s00520-014-2173-8CrossRefPubMed

116.

Koyama, N., Matsumura, C., Shitashimizu, Y., Sako, M., Kurosawa, H., Nomura, T., Eguchi, Y., Ohba, K., & Yano, Y. (2021). The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer. BMC Cancer, 21(1), 304. https://doi.org/10.1186/s12885-021-08049-3CrossRefPubMedPubMedCentral

117.

Hwang, S. S., Scott, C. B., Chang, V. T., Cogswell, J., Srinivas, S., & Kasimis, B. (2004). Prediction of survival for advanced cancer patients by recursive partitioning analysis: Role of Karnofsky performance status, quality of life, and symptom distress. Cancer Investigation, 22(5), 678–687. https://doi.org/10.1081/cnv-200032911CrossRefPubMed

118.

Vigano, A., Donaldson, N., Higginson, I. J., Bruera, E., Mahmud, S., & Suarez-Almazor, M. (2004). Quality of life and survival prediction in terminal cancer patients: A multicenter study. Cancer, 101(5), 1090–1098. https://doi.org/10.1002/cncr.20472CrossRefPubMed

119.

Shadbolt, B., Barresi, J., & Craft, P. (2002). Self-rated health as a predictor of survival among patients with advanced cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 20(10), 2514–2519. https://doi.org/10.1200/JCO.2002.08.060CrossRefPubMed

120.

Bozzetti, F., Cozzaglio, L., Biganzoli, E., Chiavenna, G., De Cicco, M., Donati, D., Gilli, G., Percolla, S., & Pironi, L. (2002). Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition (Edinburgh, Scotland), 21(4), 281–288. https://doi.org/10.1054/clnu.2002.0560CrossRefPubMed

121.

Grande, G. E., Farquhar, M. C., Barclay, S. I. G., & Todd, C. J. (2009). Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients. Palliative & Supportive Care, 7(3), 289–297. https://doi.org/10.1017/S1478951509990216CrossRef

122.

Group, T. E. (1990). EuroQol-a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208. https://doi.org/10.1016/0168-8510(90)90421-9CrossRef

123.

Hollen, P. J., Gralla, R. J., Kris, M. G., & Potanovich, L. M. (1993). Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). European Journal of Cancer (Oxford, England: 1990), 29A(Suppl 1), S51–S58. https://doi.org/10.1016/s0959-8049(05)80262-xCrossRef

124.

de Haes, J. C., van Knippenberg, F. C., & Neijt, J. P. (1990). Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. British Journal of Cancer, 62(6), 1034–1038. https://doi.org/10.1038/bjc.1990.434CrossRefPubMedPubMedCentral

125.

Spitzer, W. O., Dobson, A. J., Hall, J., Chesterman, E., Levi, J., Shepherd, R., Battista, R. N., & Catchlove, B. R. (1981). Measuring the quality of life of cancer patients: A concise QL-index for use by physicians. Journal of Chronic Diseases, 34(12), 585–597. https://doi.org/10.1016/0021-9681(81)90058-8CrossRefPubMed

126.

Groenvold, M., Petersen, M. A., Aaronson, N. K., Arraras, J. I., Blazeby, J. M., Bottomley, A., Fayers, P. M., de Graeff, A., Hammerlid, E., Kaasa, S., Sprangers, M. A., Bjorner, J. B., EORTC Quality of Life Group. (2006). The development of the EORTC QLQ-C15-PAL A shortened questionnaire for cancer patients in palliative care. European Journal of Cancer (Oxford, England: 1990), 42(1), 55–64. https://doi.org/10.1016/j.ejca.2005.06.022CrossRefPubMed

127.

Kurihara, M., Shimizu, H., Tsuboi, K., Kobayashi, K., Murakami, M., Eguchi, K., & Shimozuma, K. (1999). Development of quality of life questionnaire in Japan: Quality of life assessment of cancer patients receiving chemotherapy. Psycho-Oncology, 8(4), 355–363. https://doi.org/10.1002/(SICI)1099-1611(199907/08)8:4%3c355::AID-PON401%3e3.0.CO;2-ICrossRefPubMed

128.

Morton, R. P., & Witterick, I. J. (1995). Rationale and development of a quality-of-life instrument for head-and-neck cancer patients. American Journal of Otolaryngology, 16(5), 284–293. https://doi.org/10.1016/0196-0709(95)90055-1CrossRefPubMed

129.

Browman, G. P., Levine, M. N., Hodson, D. I., Sathya, J., Russell, R., Skingley, P., Cripps, C., Eapen, L., & Girard, A. (1993). The Head and Neck Radiotherapy Questionnaire: A morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 11(5), 863–872. https://doi.org/10.1200/JCO.1993.11.5.863CrossRefPubMed

130.

El Haidari, R., Abbas, L. A., Nerich, V., & Anota, A. (2020). Factors associated with health-related quality of life in women with breast cancer in the Middle East: A systematic review. Cancers, 12(3), 696. https://doi.org/10.3390/cancers12030696CrossRefPubMedPubMedCentral

131.

Ngo, N. T. N., Nguyen, H. T., Nguyen, P. T. L., Vo, T. T. T., Phung, T. L., Pham, A. G., Vo, T. V., Dang, M. T. N., Nguyen Le Bao, T., & Duong, K. N. C. (2023). Health-related quality of life in breast cancer patients in low-and-middle-income countries in Asia: A systematic review. Frontiers in Global Women’s Health, 4, 1180383. https://doi.org/10.3389/fgwh.2023.1180383CrossRefPubMedPubMedCentral

132.

Odeo, S., & Degu, A. (2020). Factors affecting health-related quality of life among prostate cancer patients: A systematic review. Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners, 26(8), 1997–2010. https://doi.org/10.1177/1078155220959414CrossRefPubMed

133.

Rueda, J., Solà, I., Pascual, A., & Subirana Casacuberta, M. (2011). Non-invasive interventions for improving well—being and quality of life in patients with lung cancer. The Cochrane Database of Systematic Reviews, 2011(9), CD004282. https://doi.org/10.1002/14651858.CD004282.pub3CrossRefPubMedPubMedCentral

134.

de van der Schueren, M. A. E., Laviano, A., Blanchard, H., Jourdan, M., Arends, J., & Baracos, V. E. (2018). Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: Current evidence and guidance for design of future trials. Annals of Oncology, 29(5), 1141–1153. https://doi.org/10.1093/annonc/mdy114CrossRef

135.

Mishra, S. I., Scherer, R. W., Snyder, C., Geigle, P. M., Berlanstein, D. R., & Topaloglu, O. (2012). Exercise interventions on health-related quality of life for people with cancer during active treatment. The Cochrane Database of Systematic Reviews, 2012(8), CD008465. https://doi.org/10.1002/14651858.CD008465.pub2CrossRefPubMedPubMedCentral

136.

Fukushima, T., Nakano, J., Hashizume, K., Ueno, K., Matsuura, E., Ikio, Y., Ishii, S., Morishita, S., Tanaka, K., & Kusuba, Y. (2021). Effects of aerobic, resistance, and mixed exercises on quality of life in patients with cancer: A systematic review and meta-analysis. Complementary Therapies in Clinical Practice, 42, 101290. https://doi.org/10.1016/j.ctcp.2020.101290CrossRefPubMed

137.

Molenaar, C. J., van Rooijen, S. J., Fokkenrood, H. J., Roumen, R. M., Janssen, L., & Slooter, G. D. (2022). Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. The Cochrane Database of Systematic Reviews, 5(5), CD013259. https://doi.org/10.1002/14651858.CD013259.pub2CrossRefPubMed

138.

Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., Billings, J. A., & Lynch, T. J. (2010). Early palliative care for patients with metastatic non-small-cell lung cancer. The New England Journal of Medicine, 363(8), 733–742. https://doi.org/10.1056/NEJMoa1000678CrossRefPubMed

Titel: Global quality of life and mortality risk in patients with cancer: a systematic review and meta-analysis
Auteurs: Takuya Fukushima
Katsuyoshi Suzuki
Takashi Tanaka
Taro Okayama
Junichiro Inoue
Shinichiro Morishita
Jiro Nakano
Publicatiedatum: 29-05-2024
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 10/2024
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-024-03691-3

Andere artikelen Uitgave 10/2024

Validation of the EQ-5D-Y-5L parent-proxy version among children with juvenile idiopathic arthritis

Open Access

Correction: Measuring what matters to older persons for active living: part II cross-sectional validity evidence for OPAL measure across four countries

Correction

The faces of Long-COVID: interplay of symptom burden with socioeconomic, behavioral and healthcare factors

The validity of single-item measures of health-related quality of life across groups differing in acute respiratory symptom severity

Open Access

Understanding factors impacting patient-reported outcome measures integration in routine clinical practice: an umbrella review

Open Access
Review

The FACT-GP5 as a global tolerability measure: responsiveness and robustness to missing assessments

Open Access